SCHEMBL8879490

SCHEMBL8879490

Clc1ccc(Cn2c(N3CCCNCCC3)nc3ccccc32)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 6/20 0.71
SOS1 Q07889 4/20 0.67
MEN1 O00255 2/20 0.57
MAPT P10636 2/20 0.57
KMT2A Q03164 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
KDM4E B2RXH2 1/20 0.57
GAA P10253 1/20 0.57
MAPK1 P28482 1/20 0.57
HIF1A Q16665 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
NR1I2 O75469 1/20 0.56
ABCB11 O95342 1/20 0.56
LMNA P02545 1/20 0.56
ESR1 P03372 1/20 0.56
CYP1A2 P05177 1/20 0.56
PGR P06401 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9023706 0.91 HTR3A (0.85) HTR3ASOS1
SCHEMBL20715423 0.91 CYP2D6 (0.66) HTR3ASOS1MEN1MAPTKMT2A
SCHEMBL20715427 0.90 CYP2D6 (0.64) HTR3ASOS1MEN1MAPTKMT2A
SCHEMBL8881095 0.89 HTR3A (0.86) HTR3ASOS1CYP3A4CYP2D6HRH1
SCHEMBL7623108 0.87 HTR3A (0.91) HTR3ASOS1CYP3A4CYP2D6HRH1
Lerisetron SCHEMBL30669539 0.83 HTR3A (1.00) HTR3ASOS1
Lerisetron SCHEMBL141124 0.83 HTR3A (1.00) HTR3ASOS1
Lerisetron SCHEMBL29040939 0.82 HTR3A (0.97) HTR3ASOS1
SCHEMBL7431298 0.81 HTR3A (1.00) HTR3ASOS1CYP3A4CYP2D6HRH1
SCHEMBL7341277 0.80 HTR3A (0.75) HTR3AMEN1KMT2ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624948-A TREATMENT OF BRONCHIAL ASTHMA KISSEI PHARMACEUTICAL CO., LTD. (JP) 1997-04-29 US disclosed
EP-0699668-A1 1-(2-BENZIMIDAZOLYL)-1,5-DIAZACYCLOOCTANE DERIVATIVE Kissei Pharmaceutical Co., Ltd. (JP) 1996-03-06 EP disclosed